Synthesis, kinetics and cellular studies of new phenothiazine analogs as potent human-TLK inhibitors

Delna Johnson1, Javeena Hussain1, Siddhant Bhoir2

  • 1Discipline of Chemistry, Indian Institute of Technology, Gandhinagar, Gujarat, 382355, India. priyak@iitgn.ac.in.

Insights

Researchers designed novel phenothiazine molecules as potent inhibitors of human tousled-like kinase 1B (hTLK1B). These compounds show significant promise for cancer therapy by targeting key cellular processes involved in tumor growth.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Protein kinase alterations are implicated in cancer initiation and progression.
  • Human tousled-like kinases (TLKs) regulate DNA repair, replication, and chromosomal integrity.
  • TLK1B plays a significant role in cancer development and is a potential therapeutic target.

Purpose of the Study:

  • To design and synthesize novel phenothiazine derivatives as inhibitors of human TLK1B.
  • To evaluate the biological inhibitory effects of these compounds on hTLK1B kinase activity.
  • To identify potent TLK1B inhibitors with improved properties for cancer therapy.

Main Methods:

  • Synthesis of a new class of phenothiazine molecules.
  • In vitro kinase assays using recombinant human TLK1B-kinase domain (hTLK1B-KD).
  • Cellular assays using LNCap cells and in silico studies.

Main Results:

  • Identified several phenothiazine inhibitors with superior inhibition and physicochemical properties compared to existing TLK1B inhibitors.
  • Achieved sub-nanomolar inhibitory activity against hTLK1B in LNCap cells.
  • Successfully generated a stable, catalytically active hTLK1B-KD for further studies.

Conclusions:

  • The newly designed phenothiazine analogs are potent inhibitors of hTLK1B.
  • These findings represent a crucial advancement in developing structure-based TLK-specific inhibitors for cancer treatment.
  • The identified compounds hold promise for future cancer therapeutic strategies targeting TLK1B.

Related Concept Videos

Antipsychotic Drugs: Typical and Atypical Agents01:21

Antipsychotic Drugs: Typical and Atypical Agents

Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
280
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.2K
Indirect-Acting Cholinergic Agonists: Pharmacokinetics01:22

Indirect-Acting Cholinergic Agonists: Pharmacokinetics

Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
1.1K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.5K